Risk of Urinary Tract Infection in Patients with Type 2 Diabetes Mellitus Treated with Dapagliflozin: A Systematic Review and Meta-Analysis of Randomized Controlled Trials Zhigui ZhengDongyuan HeXinxin Jiang Systematic Review 03 April 2023 Pages: 209 - 225
Does Therapeutic Repurposing in Cancer Meet the Expectations of Having Drugs at a Lower Price? Aurora Gonzalez-FierroAdriana Romo-PérezAlfonso Duenas-Gonzalez Review Article Open access 08 March 2023 Pages: 227 - 239
Vericiguat for the Treatment of Heart Failure with Reduced Ejection Fraction Following a Worsening Heart Failure Event: A Cost-Effectiveness Analysis from the Perspective of Chinese Healthcare Providers Xiangyou YuYan HaoFuqiang Liu Original Research Article 16 March 2023 Pages: 241 - 250
A Cost-effectiveness Analysis of iGlarLixi Versus IDegAsp and Appropriate Price Exploration of iGlarLixi for Type 2 Diabetes Mellitus Patients in China Yanqing JiangRuizhe LiuJianxin Pang Original Research Article 21 March 2023 Pages: 251 - 263
Sacubitril/Valsartan for Heart Failure with Preserved Ejection Fraction: A Cost-Effectiveness Analysis from the Perspective of the Chinese Healthcare System Zhe WangYake LouYuehui Wang Original Research Article 28 March 2023 Pages: 265 - 275
Subcutaneous Infliximab Monotherapy Versus Combination Therapy with Immunosuppressants in Inflammatory Bowel Disease: A Post Hoc Analysis of a Randomised Clinical Trial Geert D’HaensWalter ReinischShomron Ben-Horin Original Research Article Open access 01 April 2023 Pages: 277 - 288
Spending, Utilization, and Price Trends for Immune Checkpoint Inhibitors in US Medicaid Programs: An Empirical Analysis from 2011 to 2021 Young Eun ShinArun KumarJeff Jianfei Guo Original Research Article 01 April 2023 Pages: 289 - 298
Real-Life Experience of Tralokinumab for the Treatment of Adult Patients with Severe Atopic Dermatitis: A Multicentric Prospective Study Axel De GreefPierre-Dominique GhislainMarie Baeck Short Communication Open access 03 April 2023 Pages: 299 - 306
Feasibility of Continuous Infusion of Cefiderocol in Conjunction with the Establishment of Therapeutic Drug Monitoring in Patients with Extensively Drug-Resistant Gram-Negative Bacteria Carolin PrinzFrank StreitLars-Olav Harnisch Short Communication 05 April 2023 Pages: 307 - 314